📇 Rhumatologue · AVIGNON CEDEX 9 · (84) · Mixte
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
3 raisons identifiées
Cabinet de groupe — continuité de soins
Plusieurs praticiens dans le même cabinet — un confrère peut prendre le relais en cas d'absence
Disponibilité géographique
8 lieux d'exercice — choisissez celui qui vous arrange
Délais de RDV courts dans la région
105.8 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
INSTITUT SAINTE CATHERINE
250 CHE DE BAIGNE PIEDS CS 80005, 84918 AVIGNON CEDEX 9
CLINIQUE RHONE DURANCE
1750 CHE DU LAVARIN BP 844, 84082 AVIGNON CEDEX 2
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
SELAS IMAGES
LA MAISON BLEUE CABINET DE RADIOLOGIE 314 RUE RENE CASSIN, 84000 AVIGNON
IRM AVIGNON NORD SITE CLIN FONTVERT
235 AV LOUIS PASTEUR, 84700 SORGUES
SCANNER DES CLIN FONTVERT URBAIN V
DOMAINE DE GUERRIN 235 AV LOUIS PASTEUR, 84700 SORGUES
IMAG EN COUPES AVIG VAUCL SITE RHO DUR
1750 CHE DU LAVARIN, 84000 AVIGNON
IMAG EN COUPES AVIG VAUCL SITE STE CAT
250 CHE DE BAIGNE PIEDS CS80005, 84918 AVIGNON CEDEX 9
SELAS IMAGES
CLINIQUE FONTVERT CABINET DE RADIOLOGIE 235 AVENUE LOUIS PASTEUR, 84700 SORGUES
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Journal of pharmacokinetics and pharmacodynamics · 2005
American journal of respiratory and critical care medicine · 2025
Abstract Rationale Early detection, standardized therapy, adequate infrastructure, and strategies for quality improvement should constitute essential components of every hospital’s sepsis plan. Objectives To investigate the extent to which recommendations from the sepsis guidelines are implemented and the availability of infrastructure for the care of patients with sepsis in acute-care hospitals. Methods A multidisciplinary cross-sectional questionnaire was used to investigate sepsis care in hospitals. This included the use of sepsis definitions, the implementation of sepsis guideline recommendations, diagnostic and therapeutic infrastructure, antibiotic stewardship, and quality improvement initiatives (QIIs) in hospitals. Measurements and Main Results A total of 1,023 hospitals in 69 countries were included. Most of them, 835 (81.6%), were in Europe. Sepsis screening was used in 54.2% of emergency departments (EDs), 47.9% of wards, and 61.7% of ICUs. Sepsis management was standardized in 57.3% of EDs, 45.2% of wards, and 70.7% of ICUs. The implementation of comprehensive QIIs was associated with increased screening (EDs, +33.3%; wards, +44.4%; ICUs, +23.8% absolute difference) and increased standardized sepsis management (EDs, +33.6%; wards, +40.0%; ICUs, +17.7% absolute difference) compared with hospitals without QIIs. A total of 9.8% of hospitals had implemented ongoing QIIs, and 4.6% had invested in sepsis programs. Conclusions The findings indicate that there is considerable room for improvement in a large number of mainly European hospitals, particularly with regard to early identification and standardized management of sepsis, the availability of guidelines, diagnostic and therapeutic infrastructure, and the implementation of QIIs. Further efforts are required to implement a more comprehensive and appropriate quality of care.
Journal of clinical neuromuscular disease · 2011
Abstract We report a case of dermatomyositis associated with rheumatoid arthritis, Hashimoto thyroiditis, and diabetes mellitus responsive only to combination of rituximab with mycophenolate. A 42-year-old woman presented with proximal muscle weakness, myalgias, fever, night sweats, and shortness of breath. Creatinine kinase was 8155 IU/L, and muscle biopsy was diagnostic of dermatomyositis. She was started on glucocorticoids; her systemic symptoms improved, but her muscle weakness persisted. She was serially treated with intravenous immunoglobulin, azathioprine, and mycophenolate mofetil without improvement in her weakness. She responded dramatically to combination therapy with rituximab and mycophenolate, with improvement in strength and normalization of creatinine kinase. She has been well controlled on rituximab infusion every 6 months and maintenance mycophenolate mofetil.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
American journal of respiratory and critical care medicine · 2025 · Journal Article
Scheer CS, Giamarellos-Bourboulis EJ, Ferrer R, Idelevich EA, et al.
Immunological investigations · 1992 · Journal Article
Agris PF, Kovacs SA, Boak AM, Chen J
Journal of clinical neuromuscular disease · 2011 · Case Reports
Parziale N, Kovacs SC, Thomas CB, Srinivasan J
Journal of pharmacokinetics and pharmacodynamics · 2005 · Comparative Study
Shi J, Kovacs SJ, Wang Y, Ludden TM, et al.